ASMI congratulates Minister Ley on re-appointment 19 July 2016 The Australian Self Medication Industry (ASMI) today congratulated on Sussan Ley on her reappointment as Federal Health Minister. ASMI Chief Executive Officer, Deon Schoombie, said: “We look forward to continuing the constructive relationship we’ve had with Minister Ley and her office, and working on addressing our…

ASMI congratulates PSA Leadership Team 23 June 2016 The Australian Self Medication Industry (ASMI) today congratulated Joe Demarte on his re-election as National President of the Pharmaceutical Society of Australia (PSA), and Michelle Lynch and Dr Chris Freeman, who were elected as PSA Vice-Presidents.    ASMI Chief Executive Officer, Deon Schoombie, said: “Joe Demarte has demonstrated…

Annual Review of the ASMI Code of Practice 08 June 2016 ASMI is undertaking the annual review of our Code of Practice and as part of that review we are seeking suggestions for potential revisions to the Code. If you have any suggestions for how the ASMI Code of Practice might be revised, please complete…

ASMI congratulates Tim Roper 31 March 2016 The Australian Self Medication Industry (ASMI) congratulated and thanked Tim Roper, Executive Director, New Zealand Self Medication Industry (NZSMI), for his exceptional contribution  to the consumer healthcare products industry. Tim recently announced his retirement, which will commence at the beginning of May. ASMI Chief Executive Officer, Deon Schoombie,…

Consumer Healthcare Products fuelling strong ‘front of shop’ growth for pharmacy 17 March 2016 – Consumer healthcare products, including over-the-counter (OTC) and complementary medicines, are fuelling strong growth of pharmacy ‘front of shop’ according to the sector’s peak body, the Australian Self Medication Industry (ASMI). At APP 2016 ASMI’s Acting Chairperson, Mark Sargent, presented a…

Complementary Medicines highly regulated in Australia 15 February 2016 – The Australian Self Medication Industry (ASMI) says consumers should only purchase complementary medicines approved for supply in Australia because they are highly regulated by the Therapeutic Goods Administration (TGA). Steve Scarff, ASMI Director of Regulatory and Scientific Affairs said: “Australia’s system of regulating complementary medicines…

ASMI’s 2016 pre-Budget submission urges regulatory reforms to incentivise investment and innovation 9 February 2016 – In its 2016 pre-Budget Submission, the Australian Self Medication Industry (ASMI) proposes three regulatory reforms to incentivise investment and innovation in the non-prescription medicines sector and increase consumer access to medicines. ASMI Chief Executive Officer, Deon Schoombie, said: “The…

ASMI supports package of targeted measures for OTC codeine medicines 3 February 2016 – In its submission to the supplementary consultation on the scheduling of over-thecounter (OTC) codeine medicines, the Australian Self Medication Industry (ASMI) supported regulatory options that reduce the risk of codeine misuse, whilst retaining pharmacy access for the vast majority of consumers…

ASMI announces new Chairperson 28 January 2016 – The Australian Self Medication Industry (ASMI) today announced industry veteran, Lindsay Forrest, as its new Chairperson.   ASMI Chief Executive Officer, Deon Schoombie, congratulated and welcomed Lindsay Forrest.   “Lindsay has a long and distinguished history in the consumer healthcare products industry and is a recognised industry…

ASMI welcomes opportunity for further consultation on OTC codeine medicines 11 December 2015 – The Australian Self Medication Industry (ASMI) today welcomed the announcement by the Therapeutic Goods Administration (TGA) of a further consultation regarding scheduling of over-the-counter (OTC) codeine medicines. Steve Scarff, ASMI Regulatory and Scientific Affairs Director, said: “The TGA’s proposed amendments take…